Neurizon Therapeutics Ltd

NUZ

Company Profile

  • Business description

    Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).

  • Contact

    96-100 Albert Road
    Level 4
    South Melbourne
    MelbourneVIC3205
    AUS

    T: +61 396927222

    https://www.neurizon.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

    52

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,833.604.900.06%
CAC 407,754.5516.130.21%
DAX 4023,902.19112.080.47%
Dow JONES (US)44,838.71354.290.80%
FTSE 1008,823.2048.510.55%
HKSE24,069.94151.47-0.63%
NASDAQ20,612.96219.831.08%
Nikkei 22539,785.9023.420.06%
NZX 50 Index12,704.4879.81-0.62%
S&P 5006,282.0254.600.88%
S&P/ASX 2008,595.801.90-0.02%
SSE Composite Index3,461.156.360.18%

Market Movers